FUNDING
Applications close 5pm, Friday 30 September
Maximum award AUD $50,000
Supports the development of new or early stage collaborative research across the NHMRC Clinical Trials Centre (CTC) and University of Sydney. To undertake preliminary work to support a competitive grant submission. The majority of this funding will be provided as in-kind support by the CTC in the form of mentorship, and advice relating to areas like clinical trials design, grant development, project management and biostatistics. Researchers of various levels of experience and expertise are encouraged to apply.
Applications close 5pm, 19 October 2022
The SCP Seed Grant scheme is open to Early and Mid-Career Cancer Researchers (E/MCRs) who are SCP members working at Sydney Health Partners member institutions. SCP Seed Grants are valued at up to $20K over 12 months, with an additional amount of up to $30K available for access to research core facilities, services or equipment.
The SCP Pilot Study Grant scheme is open to all researchers who are SCP members working at Sydney Health Partners member institutions. The goal is to build research capacity in NSW by supporting researchers to conduct a pilot study that will increase the competitiveness of applications for external funding to conduct translational cancer research. SCP Pilot Study Grants are valued at up to $60K per annum, for up to 2 years.
Applications close 28 October 22
Applications close 28 Oct 22
Maximum award USD 600,000
This supports new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application with the aim of finding better treatment and cures for leukaemia, lymphoma and myeloma. Grants are worth up to USD 200,000 each per year for three years.
Applications close 31 Oct 22
Maximum award AUD 30,000
This supports research in endocrinology by postdoctoral scientists in Australia, with a focus on the areas of lipid hormone function, lipid metabolism or the metabolic regulation of human endocrine disorders. The award is worth AUD 30,000 over one year.
Applications close 06 Nov 22
Maximum award AUD 130,000
This supports Australian or New Zealand doctoral students demonstrating merit in both acquired and inherited bone marrow failure syndromes and related disorders. The scholarship is worth up to AUD 130,000 for up to three years.
Applications close 16 Nov 22 (Forecast)
Maximum award GBP 300,000
These support primary cancer prevention research research by Australian researchers. Grants are worth up to £300,000 each for up to three years.
Applications close 23 Nov 22
Maximum award AUD 2,000,000
This supports projects that aim to test and improve treatments for pancreatic cancer in Australia. Grants are worth up to AUD 2 million each for up to five years.
Applications close 30 Nov 22
Maximum award AUD 10,000
*** This opportunity will be available soon. The next call is expected to open on 1 November and close on 30 November 2022. The following information is subject to change. This supports new or existing research projects in the field of lung cancer. Grants are worth AUD 10,000 each over one year. ***
Applications close 30 Nov 22
Maximum award AUD 10,000
*** This opportunity will be available soon. The next call is expected to open on 1 November. The following information is subject to change. This grant supports research in lung cancer with a focus on genetic drivers, particularly those in never-smoking women, and precision medicine. Grants are worth AUD 10,000 over one year. ***
Applications close 30 Nov 22 (Forecast)
Maximum award AUD 10,000
*** This opportunity will be available soon. The next call is expected to open on 1 November and close on 30 November 2022. The following information is subject to change. This grant supports research into lung cancer. The grant is worth AUD 10,000 over one year. ***
Applications close 03 Dec 22 (Forecast)
Maximum award AUD 150,000
*** This opportunity will be available soon. The next call is expected to open later in 2022. The following information is subject to change. This scheme supports early- and mid-career researchers via salaried awards to promote prostate cancer research pathways which harness the clinical and psychosocial needs and interests of consumers and the broader community. Five awards are available, each ranging from AUD 100,000 to AUD 150,000 each for one year. ***
Applications close 17 Dec 22 (Forecast)
Maximum award AUD 50,000
*** This opportunity will be available soon. The following information is subject to change. This award recognises achievements in cancer research, the inclusion of consumers in research and the delivery of significant benefit to the cancer community in New South Wales. The award is worth AUD 50,000. ***
Applications close 22 Dec 22 (Forecast)
Maximum award AUD 3,000,000
This enables research teams to conduct clinical trials testing various treatment options and approaches for individuals with rare cancers, rare diseases and conditions with unmet medical need, and effective health interventions. Grants are worth up to AUD 3 million for a maximum period of five years.
